Reactome | Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial

Schema > LiteratureReference > Entries

Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial Show undefined attributes

author	[Person:9945740] Low, JG [Person:9945741] Sung, C [Person:9945747] Wijaya, L [Person:9680907] Wei, Y [Person:9945751] Rathore, APS [Person:5675980] Watanabe, S [Person:9945731] Tan, BH [Person:9945732] Toh, L [Person:9945723] Chua, LT [Person:9945750] Hou, Y [Person:9945733] Chow, A [Person:9945754] Howe, S [Person:9945738] Chan, WK [Person:9945746] Tan, KH [Person:9945734] Chung, JS [Person:9945724] Cherng, BP [Person:9945742] Lye, DC [Person:9945727] Tambayah, PA [Person:9945729] Ng, LC [Person:9945728] Connolly, J [Person:8852417] Hibberd, ML [Person:9945748] Leo, YS [Person:9945735] Cheung, YB [Person:9945242] Ooi, EE [Person:9919039] Vasudevan, SG
created	[InstanceEdit:9945736] Stephan, Ralf, 2025-04-17
dbId	9945725
displayName	Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
journal	Lancet Infect Dis
pages	706-715
pubMedIdentifier	24877997
schemaClass	LiteratureReference
title	Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
url	http://www.ncbi.nlm.nih.gov/pubmed/24877997
volume	14
year	2014

Referrals

(literatureReference)

[BlackBoxEvent:R-HSA-9919011] Pre-NS1 folds and is N-glycosylated

(author)

© 2026 Reactome

Cite Us!